These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20957868)

  • 1. Quality. Executive treatment urged to drive down infection rates.
    Sherwin J
    Hosp Health Netw; 2010 Sep; 84(9):22. PubMed ID: 20957868
    [No Abstract]   [Full Text] [Related]  

  • 2. Team-based prevention of catheter-related infections.
    Wenzel RP; Edmond MB
    N Engl J Med; 2006 Dec; 355(26):2781-3. PubMed ID: 17192545
    [No Abstract]   [Full Text] [Related]  

  • 3. Contamination of guidewires during insertion of central venous catheters in an intensive care setting.
    Palmer S; Solano T
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):506-7. PubMed ID: 16018421
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustained and prolonged reduction in central line-associated bloodstream infections as a result of multiple interventions.
    Weber DJ; Brown VM; Sickbert-Bennett EE; Rutala WA
    Infect Control Hosp Epidemiol; 2010 Aug; 31(8):875-7. PubMed ID: 20590455
    [No Abstract]   [Full Text] [Related]  

  • 5. The role and importance of cognitive studies in patient safety.
    Bates DW; Sheikh A
    BMJ Qual Saf; 2015 Jul; 24(7):414-6. PubMed ID: 26092565
    [No Abstract]   [Full Text] [Related]  

  • 6. No reason to conclude that maximal sterile barrier precautions do not reduce catheter-related blood stream infections.
    Geffers C; Meyer E
    Ann Surg; 2011 Jan; 253(1):212-3. PubMed ID: 21135688
    [No Abstract]   [Full Text] [Related]  

  • 7. Problems and solutions in hospital-acquired bacteraemia.
    Correa L; Pittet D
    J Hosp Infect; 2000 Oct; 46(2):89-95. PubMed ID: 11049700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive/Senior Leader Checklist to improve culture and reduce central line-associated bloodstream infections.
    Goeschel CA; Holzmueller CG; Berenholtz SM; Marsteller JA; Murphy DJ; Sawyer M; Duval-Arnould J; Thompson DA; Lubomski LH; Weeks K; Bauer L; Pronovost PJ
    Jt Comm J Qual Patient Saf; 2010 Nov; 36(11):519-24. PubMed ID: 21090023
    [No Abstract]   [Full Text] [Related]  

  • 9. CUSP highs and lows. Program data positive, but participation uneven.
    McKinney M
    Mod Healthc; 2012 Sep; 42(38):10. PubMed ID: 23163058
    [No Abstract]   [Full Text] [Related]  

  • 10. The preventable proportion of nosocomial infections: an overview of published reports.
    Harbarth S; Sax H; Gastmeier P
    J Hosp Infect; 2003 Aug; 54(4):258-66; quiz 321. PubMed ID: 12919755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective strategies for reducing the incidence of catheter-related bloodstream infections.
    Hitchcock J
    Br J Nurs; 2014; 23(14 Suppl):S4-10. PubMed ID: 25373250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-related bloodstream infections.
    Daley MR
    N Engl J Med; 2007 Mar; 356(12):1267-8; author reply 1268. PubMed ID: 17380574
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular catheters inserted in the trenches versus guideline documents: can the discrepancies be resolved?
    Sherertz RJ; Jarvis WR
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):887-9. PubMed ID: 14700402
    [No Abstract]   [Full Text] [Related]  

  • 14. Understaffing: a risk factor for infection in the era of downsizing?
    Farr BM
    Infect Control Hosp Epidemiol; 1996 Mar; 17(3):147-9. PubMed ID: 8708351
    [No Abstract]   [Full Text] [Related]  

  • 15. The evolving world of healthcare-associated bloodstream infection surveillance and prevention: is your system as good as you think?
    Jarvis WR
    Infect Control Hosp Epidemiol; 2002 May; 23(5):236-8. PubMed ID: 12026146
    [No Abstract]   [Full Text] [Related]  

  • 16. Catheter-related bloodstream infections.
    Jenny-Avital ER
    N Engl J Med; 2007 Mar; 356(12):1267; author reply 1268. PubMed ID: 17377167
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience.
    Ramos ER; Reitzel R; Jiang Y; Hachem RY; Chaftari AM; Chemaly RF; Hackett B; Pravinkumar SE; Nates J; Tarrand JJ; Raad II
    Crit Care Med; 2011 Feb; 39(2):245-51. PubMed ID: 21057308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes?
    Sexton DJ; Chen LF; Anderson DJ
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1286-9. PubMed ID: 20979492
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment and prevention of catheter-related infections in haemodialysis patients.
    Blankestijn PJ
    Nephrol Dial Transplant; 2001 Oct; 16(10):1975-8. PubMed ID: 11572881
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: zero tolerance for catheter-related bloodstream infections: the unnegotiable objective.
    Raad II
    Infect Control Hosp Epidemiol; 2008 Oct; 29(10):951-3. PubMed ID: 18754737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.